MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 NGS Genetic Test
Short Name: MAP2K2 CFC4 NGS Test
Also known as: CFC Syndrome Type 4, MAP2K2 Gene Mutation Test
MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last updated: September 7, 2026
Overview
To detect mutations in the MAP2K2 gene associated with Cardiofaciocutaneous syndrome type 4, aiding in diagnosis, management, and genetic counseling. NGS genetic DNA test detecets for variant and mutation detection in MAP2K2 gene for Cardiofaciocutaneous syndrome type 4
- Test Code
- 2515
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 weeks
- Fasting Required
- No
- Method
- NGS
Cardiofaciocutaneous syndrome (CFC) is a rare genetic disorder that affects multiple systems in the body. It is caused by mutations in genes that are involved in a specific pathway called the RAS/MAPK signaling pathway. One such gene is MAP2K2, which is associated with CFC syndrome type 4. In this blog, we will discuss the symptoms, diagnosis, and DNA test cost for MAP2K2 gene-related CFC syndrome type 4.
Symptoms of CFC Syndrome Type 4
CFC syndrome type 4 is characterized by a combination of symptoms that affect the heart, face, and skin. Some of the common symptoms include:
- Heart abnormalities such as congenital heart defects or arrhythmia
- Dysmorphic facial features such as a large forehead, wide-set eyes, and a small chin
- Abnormal skin pigmentation, dry skin, and eczema
- Delayed development, intellectual disability, and behavioral problems
These symptoms can vary in severity and may not always be present in individuals with CFC syndrome type 4. It is important to note that not all individuals with MAP2K2 gene mutations will develop CFC syndrome type 4.
Diagnosis of CFC Syndrome Type 4
CFC syndrome type 4 is a rare genetic disorder, and diagnosis can be challenging. A clinical diagnosis is usually made based on the presence of characteristic symptoms and physical findings. However, genetic testing can confirm the diagnosis and identify the underlying genetic mutation.
Next-generation sequencing (NGS) is a powerful tool for genetic testing and can detect mutations in multiple genes simultaneously. NGS-based genetic testing for MAP2K2 gene mutations is available in India and can be performed on a blood or saliva sample. The test cost for MAP2K2 gene-related CFC syndrome type 4 is approximately INR 20,000.
Conclusion
CFC syndrome type 4 is a rare genetic disorder caused by mutations in the MAP2K2 gene. It is characterized by a combination of symptoms that affect the heart, face, and skin. Diagnosis can be challenging, but genetic testing can confirm the diagnosis and identify the underlying genetic mutation. NGS-based genetic testing for MAP2K2 gene mutations is available in India for approximately INR 20,000. Early diagnosis and management can improve the quality of life for individuals with CFC syndrome type 4 and their families.
If you suspect that you or your child may have CFC syndrome type 4, it is important to consult with a healthcare professional who can provide a thorough evaluation and appropriate genetic testing.
Sample Collection
No special preparation required. Genetic counseling is recommended prior to testing.
Method: Venipuncture or FTA Card
Laboratory Analysis
A blood sample will be drawn by a trained phlebotomist using sterile techniques.
Report Delivery
Apply pressure to the puncture site to prevent bleeding. Resume normal activities.
Timeline: 3 to 4 weeks
Patient Instructions
About This Test
Who Should Get This Test
To detect mutations in the MAP2K2 gene associated with Cardiofaciocutaneous syndrome type 4, aiding in diagnosis, management, and genetic counseling.
NGS genetic DNA test detecets for variant and mutation detection in MAP2K2 gene for Cardiofaciocutaneous syndrome type 4
How to Prepare
- Ensure proper patient identification
- Use sterile collection equipment
- Label samples accurately
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"Early genetic testing for CFC syndrome type 4 can guide management, inform treatment options, and support family planning decisions."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted samples
- Insufficient sample volume
- Improper labeling
Understanding Your Results
Pathogenic variant detected
Consistent with Cardiofaciocutaneous syndrome type 4. Clinical correlation and genetic counseling are recommended.
No pathogenic variant detected
CFC syndrome type 4 is unlikely, but further clinical evaluation may be needed if symptoms persist.
If symptoms of CFC syndrome are present, such as heart defects, facial abnormalities, skin issues, or developmental delays, or if there is a family history of the disorder.
Limitations
- ⚠May not detect all genetic variants
- ⚠Requires clinical correlation and genetic counseling
Risks & Considerations
- ●Minimal risk from blood draw (e.g., bruising, infection)
- ●Potential psychological impact of results
Interfering Factors
- ●Sample degradation
- ●Contamination during collection or processing
Frequently Asked Questions
What is MAP2K2 Gene Cardiofaciocutaneous syndrome type 4?
What are the common symptoms of CFC syndrome type 4?
How is CFC syndrome type 4 diagnosed?
What is the cost of the MAP2K2 Gene NGS Genetic Test?
Is home sample collection available for this test?
How long does it take to get the test results?
What sample type is required for the test?
Is fasting required before the test?
Who should consider this genetic test?
What does a positive test result mean?
Can this test be used for prenatal diagnosis?
Is genetic counseling recommended before and after the test?
Related Tests
APOB Gene Hypercholesterolemia type B autosomanl dominant NGS Genetic Test
₹20,000MICM (Maternally Inherited Cardiomyopathy) Mutation Detection Test
₹10,500EPHX2 Gene Hypercholesterolemia, familial, due to LDLR defect, modifier of NGS Genetic Test
₹20,000DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 NGS Genetic Test
₹20,000KCNA5 Gene Atrial fibrillation type 7 NGS Genetic Test
₹20,000MYH6 Gene Atrial septal defect type 3 NGS Genetic Test
₹20,000Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.